Genomic News and Research

RSS

Salivary miRNAs may be a promising biomarker for persistent post-concussive symptoms in children

Predicting clinical recovery of children with concussion is challenging. While concussion symptoms typically resolve within one to three weeks, up to one-third of children develop persistent post-concussive symptoms (PPCS), including headache, nausea, dizziness, blurred vision and sensitivity to light and/or sound.

26 Oct 2022

Saving ocean habitats with newer genomic technologies

In an essay published on October 17th, 2022 in the open-access journal PLOS Biology, Madeleine van Oppen of the Australian Institute of Marine Science and the University of Melbourne and Melinda Coleman of the New South Wales Department of Primary Industries argue that genetic and genomic technologies have tremendous potential for protecting marine life but are currently underutilized.

20 Oct 2022

Large 'omics' dataset reveals a year in the biological life of Arctic Ocean

A major new project will help benchmark biodiversity change in the Arctic Ocean and guide conservation efforts by identifying unique species and assessing their extinction risk.

18 Oct 2022

High-quality chromosome-level reference genome for A. gigantea

According to the International Union for Conservation of Nature’s Red List, Aldabra giant tortoises are in danger of extinction, which means the species stands a high risk of extinction in the wild.

14 Oct 2022

A more efficient way to deliver gene therapies to the CNS

For gene therapy, the blood-brain barrier (BBB) poses a formidable obstacle. The BBB, which is made up of cells that are closely packed together, prevents poisons and pathogens from accessing brain tissue while also blocking potential treatments for diseases that impact the CNS.

12 Oct 2022

New technique identifies tumor-associated microbes

Researchers from Rutgers Cancer Institute of New Jersey and RWJBarnabas Health investigated the microbiome of pancreatic tumors and discovered certain microbes linked to inflammation and poor survival.

From Rutgers University 12 Oct 2022

Genomic research helps in tackling the fatal complications of fungal infections

An important genetic discovery made by a research team led by a University of Massachusetts Amherst scientist sheds new light on the application of the drug caspofungin to treat the deadly fungal infection Aspergillus fumigatus, which claims the lives of about 100,000 severely immunocompromised individuals every year.

7 Oct 2022

Single-cell functional tool screens active ARB in native soils

Soil antimicrobial resistance (AMR) poses significant health risks due to the possibility of transfer to humans via direct contact and the food chain.

3 Oct 2022

Newly isolated Bacteroides likely to be present in mammals beyond mice

In the DFG-funded Collaborative Research Center (CRC) 1182 “Origin and Function of Metaorganisms,” scientists from Kiel University and the Max Planck Institute for Evolutionary Biology in Plön (MPI-EB) are investigating the evolutionary history and function of Bacteroides.

From The Max Planck Institute 30 Sep 2022

“Junk” DNA could provide access to innovative treatments for neurological conditions

The breakthrough study from the University of Sheffield’s Neuroscience Institute and Healthy Lifespan Institute offers critical new insights into the so-called junk DNA, or DNA that was previously believed to be unimportant to the coding of the genome, and how it affects neurological disorders like Motor Neuron Disease (MND) and Alzheimer’s.

29 Sep 2022

Discovery of genes lending tolerance to sugarcane from pests, cold, and drought

Saccharum spontaneum, a species of wild sugarcane with exceptional resistance to biotic stresses like nematodes, fungi, bacteria, and other pests and diseases, as well as abiotic stresses like cold, drought, salinity, and nutritionally deficient soil, was the subject of a study at the State University of Campinas (UNICAMP) in Brazil.

28 Sep 2022

WEHI receives $2.5 million fund to develop personalized cancer treatments

With a $2.5 million fund received from the Medical Research Future Fund (MRFF), a new genomics project led by WEHI will develop precision medicine and customized cancer therapy for Australians.

From Walter and Eliza Hall Institute of Medical Research (WEHI) 27 Sep 2022

Tiny DNA strand net in a low-cost test platform traps COVID-19 virus

According to a new study, tiny nets made of DNA strands can capture the spike protein of the virus that causes COVID-19, illuminating it for a quick yet accurate diagnostic test and preventing it from infecting cells, suggesting a new potential path to antiviral treatment.

26 Sep 2022

Coral genome reveals cysteine biosynthesis pathways

Model animals, such as mice and fruit flies, have provided scientists with powerful insights into how cellular biology works. However, model animals are really just a guide, and it can be risky to generalize findings across animals from studying a selection of model organisms.

26 Sep 2022